Skip to Content

M P5 (Paroxetine Extended-Release 37.5 mg)

Pill imprint M P5 has been identified as Paroxetine hydrochloride extended-release 37.5 mg.

Paroxetine is used in the treatment of anxiety and stress; anxiety; generalized anxiety disorder; depression; dysautonomia (and more), and belongs to the drug class selective serotonin reuptake inhibitors. Excluding Brisdelle: There is positive evidence of human fetal risk during pregnancy. Brisdelle: Not for use in pregnancy. Paroxetine 37.5 mg is not subject to the Controlled Substances Act.

See also related documents.

Paroxetine hydrochloride extended-release 37.5 mg M P5
Paroxetine hydrochloride extended-release 37.5 mg M P5
Paroxetine hydrochloride extended-release
Imprint:
M P5
Strength:
37.5 mg
Color:
Orange
Shape:
Round
Availability:
Prescription only
Drug Class:
Selective serotonin reuptake inhibitors
Pregnancy Category:
D - Positive evidence of risk - excluding Brisdelle
X - Not for use in pregnancy - Brisdelle
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Mylan Pharmaceuticals Inc.

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2015 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

(web2)